We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-34.3%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$115M
AUM Growth
+$792K
Cap. Flow
+$6.43M
Cap. Flow %
5.6%
Top 10 Hldgs %
83.12%
Holding
142
New
32
Increased
15
Reduced
32
Closed
53

Top Buys

Rank Stock Value
1
RCON icon
Recon Technology
RCON
+$5M
2
GMVD
G Medical Innovations Holdings Ltd. Ordinary Shares
GMVD
+$3.87M
3
BETS
Bit Brother Limited Class A Ordinary Shares
BETS
+$2.24M
4
CNEY icon
CN Energy Group
CNEY
+$2.19M
5
NMTR
9 Meters Biopharma
NMTR
+$2.08M

Top Sells

Rank Stock Value
1
NVCT icon
Nuvectis Pharma
NVCT
+$4.41M
2
TBLT
ToughBuilt Industries, Inc. Common Stock
TBLT
+$2.28M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$1.92M
4
BGXX
Bright Green Corporation Common Stock
BGXX
+$1.49M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.34M

Sector Composition

Rank Sector Weight
1 Healthcare 9.81%
2 Technology 3.12%
3 Consumer Discretionary 2.1%
4 Communication Services 1.53%
5 Materials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BGXX
76
PUT
DELISTED
Bright Green Corporation Common Stock
BGXX
$43.1K 0.04%
+458
New +$366
SMFL
77
DELISTED
Smart for Life, Inc. Common Stock
SMFL
$42.7K 0.04%
94
-49
-34% -$29.7K
HCDIZ
78
DELISTED
Harbor Custom Development, Inc. Warrant
HCDIZ
$40K 0.03%
801,422
-266,494
-25% -$16K
CAN
79
CALL
Canaan Creative
CAN
$172M
$38.1K 0.03%
141
– –
GEVO icon
80
PUT
Gevo
GEVO
$353M
$30.8K 0.03%
200
-450
-69% -$852
APDNW
81
CALL
DELISTED
Applied DNA Sciences Inc Warrant
APDNW
$27.6K 0.02%
+244
New +$27.6K
CBAT icon
82
CBAK Energy Technology Ltd
CBAT
$43.1M
$25.9K 0.02%
29,400
+5,484
+23% +$5.7K
CBAT icon
83
PUT
CBAK Energy Technology Ltd
CBAT
$43.1M
$25.9K 0.02%
294
-604
-67% -$628
NCPL icon
84
Netcapital
NCPL
$2.83M
$23.4K 0.02%
336
-1,095
-77% -$95.3K
ANY icon
85
CALL
Sphere 3D
ANY
$15.7M
$19.8K 0.02%
8
– –
OPTT icon
86
Ocean Power Technologies
OPTT
$41.5M
$14.1K 0.01%
26,597
+2,695
+11% +$1.65K
BIOC
87
DELISTED
Biocept, Inc.
BIOC
$10.1K 0.01%
987
-30
-3% -$434
NEXRW
88
Nexera Technologies Ltd Warrant
NEXRW
$6.6K 0.01%
77,282
– –
BBLGW
89
Bone Biologics Corp Warrants
BBLGW
$32.7M
$4.3K ﹤0.01%
3,583
– –
AGMH icon
90
AGM Group Holdings
AGMH
$1.67M
– –
-2,897
Closed -$239K
AMPG icon
91
AmpliTech
AMPG
$117M
– –
-135,482
Closed -$287K
ATNM icon
92
CALL
Actinium Pharmaceuticals
ATNM
$26.3M
– –
-288
Closed -$307K
ATNM icon
93
PUT
Actinium Pharmaceuticals
ATNM
$26.3M
– –
-1,921
Closed -$2.05M
ATOS icon
94
CALL
Atossa Therapeutics
ATOS
$23M
– –
-38
Closed -$30.2K
BCTX
95
Briacell Therapeutics
BCTX
$29.6M
– –
-79
Closed -$52K
BJDX icon
96
Bluejay Diagnostics
BJDX
$909K
– –
-1
Closed -$9.91K
BLRX
97
BioLineRX
BLRX
$12M
– –
-43,800
Closed -$1.03M
BTCT icon
98
BTC Digital
BTCT
$8.69M
– –
-29,681
Closed -$104K
BNC
99
CEA Industries
BNC
$103M
– –
-9,400
Closed -$94.8K
CING icon
100
Cingulate
CING
$61M
– –
-92
Closed -$22K
2 3
4
5 6

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
AB
Aozora Bank Tokyo, Japan $43.6M AUM 1.15% 1-Year Est. Return

Sabby Management's Q1 2023 Portfolio in Review

As of Q1 2023, Sabby Management held 142 positions worth $115M, up 0.69% from $114M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Sabby Management deployed $6.43M of net new capital in Q1 2023, opening 32 new positions and adding to 15 existing holdings. Its largest new stake was Recon Technology: 219,315 shares worth $1.35M.

By sector, the portfolio is most concentrated in Healthcare at 9.8% of assets, down from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Cocrystal Pharma, an estimated $792K trimmed.

  • Sabby Management's largest Q1 2023 buy was Recon Technology: 219,315 shares worth $1.35M.
  • Sabby Management added most to Akari Therapeutics in Q1 2023, an estimated $1.68M increase.
  • Sabby Management's biggest Q1 2023 reduction was Cocrystal Pharma, cutting an estimated $792K.
  • Sabby Management fully exited Nuvectis Pharma in Q1 2023, selling an estimated $4.41M.
  • Sabby Management's ten largest holdings make up 83% of its $115M portfolio in Q1 2023.
  • Sabby Management opened 32 new positions and closed 53 in Q1 2023.
  • Sabby Management's portfolio value rose 0.69% quarter-over-quarter to $115M.

Based on Sabby Management's 13F filing for Q1 2023, filed 15 May 2023.